Prevention of sudden cardiac death: a current perspective.
Domanski
M J
MJ
Clinical Trials Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892, USA.
Exner
D V
DV
D000638:Amiodarone / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000401:mortality / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D004554:Electric Countershock / Q000295:instrumentation; D006323:Heart Arrest / Q000150:complications / Q000401:mortality / Q000628:therapy; D006333:Heart Failure / Q000150:complications / Q000401:mortality / Q000628:therapy; D006801:Humans; D016032:Randomized Controlled Trials as Topic